Grifols, S.A.'s revenue has grown 7.5% a year over three years, and grown 7.1% a year over five, with earnings per share compounding at 30%. Revenue growth, 3-year annual rate: +7.5% (Drug Manufacturers - General median +5.1%). Revenue growth, 5-year rate: +7.1%, growth has picked up over the last three years. Earnings per share, 3-year rate: +30%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 11, FY2015 to FY2025, as filed.

GRFSGrifols, S.A.

Healthcare

$7.54-23% 1Y

$7.54

$7.0052 weeks$9.72

Is it growing?

Good

Growing: earnings up +157% year on year and operating margin widening (+4.5 points).

2 good, 1 neutral

Revenue trend+4% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +7% a year.

Earnings trend+157% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+4.5 points operating

Trailing-twelve-month operating margin, 16.5% now against 12.1% a year earlier.

All from SEC EDGAR, as of Dec 31, 2025.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is GRFS growing?

Grifols, S.A.'s revenue has grown 7.5% a year over three years, and grown 7.1% a year over five, with earnings per share compounding at 30%.

+7.5%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +5.1% · steady growth, ahead of inflation · compounded from fiscal years as filed

Revenue growth, 5-year rate: +7.1%
Revenue growth, 5-year rate · +7.5% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +30%
Earnings per share, 3-year rate · revenue +7.5% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed